Appointment dossier — Glioblastoma
Bring this to your appointment. It summarizes what published studies report — it is not medical advice and does not say anything works. Decisions are yours and your care team’s.
Compounds studied in Glioblastoma
- Temozolomide — Human evidence · 2 positive / 1 negative-mixed · PMID 40466642, 36067704, 38672566, 38630257
- Pembrolizumab — Human evidence · 1 positive · PMID 40466642
- Bevacizumab — Review evidence · 0 positive / 1 negative-mixed · PMID 35806212, 26664126
“Positive” means a study reported a positive result — most are early lab/animal work that may not translate to people.
Open recruiting trials (18)
- NCT06496971 · Phase 3 — A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients (Taiwan)
- NCT05669820 · Phase 2 / Phase 3 — Antisecretory Factor Glioblastoma Phase 2 (Sweden)
- NCT05463848 · Phase 2 — Surgical Pembro +/- Olaparib w TMZ for rGBM (United States)
- NCT06016452 · Phase 2 — A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma (India)
- NCT06991101 · Phase 2 — Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma (United States)
- NCT07003542 · Phase 2 — A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas (United States)
- NCT03603405 · Phase 1 / Phase 2 — HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM (United States)
- NCT07501559 · Phase 1 / Phase 2 — A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM) (China)
- NCT04523688 · Phase 2 — Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma (Italy)
- NCT04765098 · Phase 2 — Tamoxifen Versus Etoposide After First Recurrence in GBM Patients (Canada)
- NCT05653622 · Phase 2 — Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma (France)
- NCT07476794 · Phase 2 — Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma (Canada)
- NCT06815432 · Phase 1 — GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma (United States)
- NCT07541781 · Phase 1 — Sitagliptin in Recurrent/Progressive Grade 4 Glioma (United States)
- NCT05083754 · Phase 1 — Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma (United States)
- NCT06894979 · Phase 1 — Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma (United States)
- NCT07268053 · Early Phase 1 — A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases (United States)
- NCT07648823 · Early Phase 1 — Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma (China)
Most-relevant first: trials that name Glioblastoma, then broader trials you may still qualify for. 322 recruiting trials name this cancer on ClinicalTrials.gov. Eligibility is decided by each trial's team — bring these NCT numbers to your appointment.
Financial help to look into
- PAN Foundation — Copay assistance funds by diagnosis (funds open and close as money allows). https://www.panfoundation.org/
- HealthWell Foundation — Copay and premium assistance funds by disease. https://www.healthwellfoundation.org/
- CancerCare — financial assistance — Limited grants plus free financial counseling. https://www.cancercare.org/financial
- Family Reach — Help with everyday living costs (rent, transport, food) during treatment. https://familyreach.org/
- NeedyMeds — Searchable directory of drug patient-assistance and discount programs. https://www.needymeds.org/
For each medicine above, search manufacturer and nonprofit programs at medicineassistancetool.org.
Questions to ask your oncologist
- I've read that Temozolomide has been studied in people for Glioblastoma — what's the evidence, and is it an option or available in a trial for me?
- I've read that Pembrolizumab has been studied in people for Glioblastoma — what's the evidence, and is it an option or available in a trial for me?
- Of the open trials I found (for example NCT06496971), am I eligible for any — here or at a larger cancer center?
- What is my exact diagnosis — the type, subtype, stage, and grade?
- Has my tumor had molecular or genomic testing (e.g. next-generation sequencing), and what did it find?
- Should I have inherited (germline) genetic testing, and could it affect my treatment or my family?
- What is the goal of treatment for me — cure, long-term control, or comfort?
- What are all of my standard treatment options, and what does each one involve?
- What is the realistic benefit of each option, in actual numbers?
- What are the most common and the most serious side effects, and how are they managed?
- How will we know if treatment is working, and how often will I be scanned or tested?
- If the first treatment doesn't work, what are the next options?
- Are there gentler options if I want to prioritize quality of life?
- Am I eligible for any clinical trials — here or at a larger/academic cancer center?
- Is my case reviewed by a multidisciplinary tumor board?
- Would a second opinion at a center that treats my cancer often be worthwhile?
- Could any of my prescriptions, over-the-counter drugs, or supplements interfere with treatment?
- Which symptoms are emergencies, and who do I call after hours?
- Should I see palliative or supportive care alongside my treatment?
- How will treatment affect my daily life, work, and (if it matters to me) fertility?
- What can I safely do myself — diet and activity — and is anything I'm taking risky?
- What will treatment cost, and is financial assistance available?